Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study. (Q45271732)

From Wikidata
Revision as of 19:37, 18 August 2019 by Simon Villeneuve (talk | contribs) (‎Created claim: language of work or name (P407): English (Q1860), #petscan)
Jump to navigation Jump to search
scientific article
Language Label Description Also known as
English
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.
scientific article

    Statements

    title
    Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    15718320
    retrieved
    11 December 2017
    author name string
    Jacques-Henri Jacob
    series ordinal
    5
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    15718320
    retrieved
    11 December 2017
    Jean-Philippe Metges
    series ordinal
    8
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    15718320
    retrieved
    11 December 2017
    Emmanuelle Magherini
    series ordinal
    11
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    15718320
    retrieved
    11 December 2017

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q45271732&oldid=998415065"